Navigating the Complex Web: Obesity’s Impact on Type 2 Diabetes Mellitus

Introduction¹

The global prevalence of obesity and Type 2 Diabetes Mellitus (T2DM) has surged over the last two decades, presenting a significant public health crisis. These metabolic disorders share a commonality in their pathogenic mechanisms, encompassing genetics/epigenetics, environmental factors, and immunometabolism. While lifestyle changes and bariatric surgeries are recognized as effective interventions, this article extensively explores the epidemiological, pathogenic, and therapeutic links that bind obesity and T2DM.

Epidemiological Links Between Obesity and T2DM

Obesity ^2,4

Obesity, characterized as a chronic ailment impacting both physical and mental well-being, is the outcome of a complex interplay involving genetics, biology, lifestyle, and environmental factors. However, the prevalent use of BMI as a measure fails to address the multifaceted nature of this issue. Inadequate policies contribute to the rising trends in obesity, with varying perceptions of this condition across different cultures. Vulnerable populations, particularly women and children, bear a more substantial brunt of this epidemic. Addressing the impacts and consequences of obesity necessitates timely intervention through effective strategies.

Type 2 Diabetes Mellitus (T2DM)^5,7

Type 2 Diabetes Mellitus (T2DM), primarily rooted in insulin deficiency or resistance, is intrinsically tied to factors such as obesity, aging, family history, and ethnicity. This condition is preventable and manageable, yet it afflicts approximately 10.5% of the world’s population, with half of these cases undiagnosed. Projections indicate that diagnosed cases will surge from 537 million in 2021 to 783 million by 2045, with over 90% of these undiagnosed cases concentrated in low- and middle-income countries. Obesity remains a critical driver of Type 2 diabetes, with youths increasingly vulnerable to cardiometabolic complications compared to Type 1 diabetes.

Factors Linking Obesity to Type 2 Diabetes Mellitus

1. Islet Function: Genetic and Environmental Factors ⁸

Obesity’s significant role in the development and progression of Type 2 Diabetes Mellitus (T2DM) is attributable to genetic/epigenetic susceptibility, alterations in the microenvironment that impair insulin signaling, compromised β-cell function, and perturbations in the microbiome-gut-brain axis. Notably, in  rare instances, Type 2 Diabetes Mellitus (T2DM) can manifest before obesity in individuals with inherent insulin resistance.

Figure 1: Genetic and environmental factors affecting islet function and connecting obesity and Type 2 Diabetes Mellitus (T2DM).

2. Microenvironmental Reorganisation in Relation to Obesity ^4,6,10,11

Obesity’s hallmark is the accumulation of excess body fat. Expressing adipose tissue beyond its typical locations generates specific metabolites and inflammatory cytokines. This leads to systemic inflammation, causing cellular dysfunction, hindering insulin signaling, disrupting metabolic regulation, impairing β-cell function, and culminating in hyperglycemia, thereby fostering T2DM.

Ectopic expansion of adipose tissue, marked by white adipocyte growth, is pivotal in exacerbating insulin resistance and promoting steatosis. Further complicating matters, the obese microenvironment introduces hypoxia, fibrosis, and mitochondrial dysfunction, contributing to T2DM development. Elevated levels of free fatty acids can further compromise β-cell function. However, paradoxically, a healthier expansion of adipose tissue can have a protective effect, often termed the “obesity paradox,” and improve patient prognosis in conditions like cardiovascular disease and cancer.

2.1 Nutrients and Metabolite ⁴

Obesity mediates insulin resistance through various metabolic pathways, including fatty acids, amino acids, and other metabolites. The type of lipid accumulated in the body significantly affects insulin sensitivity. Whereas saturated fatty acids (SFAs) exert negative influences, polyunsaturated fatty acids (PUFAs), monounsaturated fatty acids (MUFAs), and fatty acid esters of hydroxy fatty acids (FAHFAs) demonstrate anti-inflammatory and insulin-sensitizing properties. On the other hand, Diacylglycerol (DAG) and ceramides undermine insulin sensitivity, while specific phospholipids play regulatory roles. Among amino acids, branched-chain amino acids (BCAAs) have notable associations with metabolic syndrome and cardiovascular risk in the context of obesity.

Additionally, methionine and certain aromatic amino acids can trigger insulin resistance and T2DM. Effectively managing methionine intake can enhance energy levels, insulin sensitivity, and adiponectin secretion. Although elevated levels of aromatic amino acids are linked to overconsumption of glucose, they still lack clear causation concerning high BCAA levels and T2DM.

2.2 Systemic Inflammation ⁴

Obesity prompts inflammation, resulting in tissue damage and the loss of β-cell mass, leading to T2DM. Pro-inflammatory cytokines dampen insulin signaling, while anti-inflammatory counterparts decrease in the context of tissue remodeling. Chronic inflammation and the expansion of adipose tissue collaboratively contribute to insulin resistance, fibrosis, adipocyte dysfunction, and cellular apoptosis.

3. Autophagy ¹⁰

Autophagy, responsible for recycling cellular components and eliminating harmful cells, plays a pivotal role in metabolic disorders and diseases. Alterations in nutrients, metabolism, and the microenvironment impact autophagy. Suppressed autophagy disrupts adipose tissue development and function, accumulating visceral fat and insulin resistance. Dysfunction in autophagy can contribute to the expansion of fatty tissue, inflammation, and the development of Type 2 diabetes.

4. β-Cell Failure in Pancreatic Islets ¹¹

Type 2 diabetes is characterized by β-cell loss and impaired glucose-stimulated insulin secretion, with endoplasmic reticulum (ER) stress, glucolipotoxicity, and amyloid deposition contributing to these impairments. However, several therapeutic approaches exhibit promise in reactivating β-cell neogenesis and regeneration, holding potential for a cure for T2DM. Low-calorie Mediterranean-style or low-carbohydrate dietary regimens can alleviate insulin resistance and β-cell function, offering preferable strategies for addressing obesity and T2DM.

5. The Microbiome-Gut-Brain Axis ⁶

Figure 2: Regulators of the microbiome-gut-brain axis.

The gut microbiome is pivotal in regulating metabolic processes, energy balance, and insulin signaling, closely associating it with metabolic diseases like obesity and T2DM. Diet is the primary determinant of gut microbiome composition, and fluctuations in this composition wield influence over the development of T2DM. Dysregulation of bile acid metabolism and dysbiosis contribute to metabolic disorders in the context of obesity and T2DM. Excessive food consumption influences the gut microbiome and fuels extreme energy consumption, promoting obesity and T2DM, particularly due to disruptions in gut-brain interactions.
 

The Interaction of Current Obesity and Type 2 Diabetes Mellitus (T2DM) Therapies ⁶

Since T2DM is inherently tied to obesity, addressing obesity often leads to the resolution of T2DM. Some anti-diabetic medications also offer the potential to reduce body weight, creating a synergy between managing both conditions. Effective treatments span lifestyle interventions, pharmacotherapy, medical devices, and bariatric surgery.

Lifestyle Interventions ⁶

Lifestyle interventions are prime in managing obesity and T2DM due to their cost-effectiveness and limited side effects. These encompass behavioral strategies such as self-monitoring, behavioral contracts, and goal setting that boost adherence to healthier habits. Weight loss is achieved through a low-calorie diet, increased physical activity, and emerging.

Conclusion

The global health issues of obesity and T2DM are highly complex and multifactorial, involving genetic, environmental, and lifestyle factors. These conditions have significant adverse consequences on physical and mental health, particularly among vulnerable populations such as women and children, and require urgent action to prevent their long-term effects. Treatment options for obesity and T2DM include lifestyle interventions such as diet and exercise, pharmacotherapy, medical devices, and bariatric surgery.

However, the efficacy of these treatments varies depending on individual circumstances, and more research is needed to develop effective strategies for prevention and management. Given the complex interplay of genetic, environmental, and lifestyle factors involved in these conditions, a collaborative and integrated approach is necessary to address these intertwined health issues. ^1,5,9

---

References

1. Tsai AG, Bessesen DH. Obesity. Ann Intern Med (2019) 170(5):Itc33–itc48. doi: 10.7326/aitc201903050
2. Kumanyika S, Dietz WH. Solving population-wide obesity – progress and future prospects. N Engl J Med (2020) 383(23):2197–200. doi: 10.1056/NEJMp2029646
3. Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol (2019) 15(5):288–98. doi: 10.1038/s41574-019-0176-8
4. World Obesity Federation. World obesity atlas 2022. (London: World Obesity Federation) (2022). Available at: https://data.worldobesity.org/publications/?cat=15.
5. International Diabetes Federation (IDF). IDF Diabetes Atlas, 10th ed. Brussels: International Diabetes Federation (IDF). (2022). Available at: https://diabetesatlas.org/atlas/tenth-edition/.
6. Piché M-E, Tchernof A, Després J-P. Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res (2020) 126(11):1477–500. doi: 10.1161/CIRCRESAHA.120.316101
7. Ingelsson E, McCarthy MI. Human genetics of obesity and type 2 diabetes mellitus: past, present, and future. Circ Genom Precis Med (2018) 11(6):e002090. doi: 10.1161/CIRCGEN.118.002090
8. Eizirik DL, Pasquali L, Cnop M. Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat Rev Endocrinol (2020) 16(7):349–62. doi: 10.1038/s41574-020-0355-7
9. Arteburn DE, Telem DA, Kushner RF, et al. Benefits and risks of bariatric surgery in adults: a review. Jama (2020) 324(9):879-87. Doi: 10.1001/jama.2020.12567
10. Kim KH, Lee MS. Autophagy–a key player in cellular and body metabolism. Nat Rev Endocrinol (2014) 10(6):322–37. doi: 10.1038/nrendo.2014.35
11. Eizirik DL, Pasquali L, Cnop M. Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat Rev Endocrinol (2020) 16(7):349–62. doi: 10.1038/s41574-020-0355-7

About Docquity

Docquity is an AI-based state-of-the-art private & secure continual learning network of verified doctors, bringing you real-time knowledge from thousands of doctors worldwide. Today, Docquity has over 400,000 doctors spread across six countries in Asia. 

Meet experts and trusted peers across Asia where you can safely discuss clinical cases, get up-to-date insights from webinars and research journals, and earn CME/CPD credits through certified courses from Docquity Academy. All with the ease of a mobile app available on Android & iOS platforms!